Editorial Board Member - JHBD
Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head of Epigenetics Laboratory.
Dr. Cheng came back to become a faculty in the Hematopathology Section at University of Chicago in 2013. He has quite a few scientific publications and a patent issued by the U.S. patent agency. He also had multiple awards including Cancer Research Foundation Young Investigator Award, the society for Hematopathology Pathologist-in-Training Award, the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists, the Robert E. Priest Fellowship, …etc.
Dr. Jason X. Cheng’s research interest includes:
- Genetic and epigenetic controls of hematopoiesis
- Hematopoietic stem cell differentiation and lineage specification.
- Pathogenesis of anemia
- Myeloproliferative neoplasms
- Myelodysplastic syndrome
Other Editorial Board Members - JHBD
Department of Molecular & Clinical Pharmacology
Institute of Translational Medicine
University of Liverpool
Division of Hematology/Medical Oncology University of Missouri
Istanbul University Oncology Institute
Mansoura Faculty of Medicine
Department of Internal Medicine
University Hospital of Strasbourg
Baylor College of Medicine
Division of Hematology/Oncology
School of Medicine
Case Western Reserve University
Memorial Sloan Kettering Cancer Center